Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mesalazine 1g suppositories
0105010B0AAAJAJ
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 16,631 |
|
Mesalazine 500mg modified-release tablets
0105010B0AAAIAI
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 8,174 |
|
Mesalazine 1.2g gastro-resistant modified-release tablets
0105010B0AAARAR
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 6,565 |
|
Mesalazine 400mg gastro-resistant tablets
0105010B0AAAAAA
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 6,044 |
|
Mesalazine 800mg gastro-resistant tablets
0105010B0AAASAS
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 5,589 |
|
Mesalazine 500mg suppositories
0105010B0AAABAB
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 5,196 |
|
Mesalazine 1g/application foam enema
0105010B0AAAKAK
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 4,428 |
|
Mesalazine 1g modified-release tablets
0105010B0AAAYAY
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 3,379 |
|
Mesalazine 2g modified-release granules sachets sugar free
0105010B0AAATAT
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 2,668 |
|
Mesalazine 2g/59ml enema
0105010B0AAALAL
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 2,346 |
|
Mesalazine 3g gast res MR gran sachets sugar free
0105010B0AAAZAZ
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 1,655 |
|
Mesalazine 1g modified-release granules sachets sugar free
0105010B0AAANAN
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 1,635 |
|
Mesalazine 1g gast res MR gran sachets sugar free
0105010B0AAAXAX
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 1,406 |
|
Mesalazine 1g/100ml enema
0105010B0AAACAC
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 1,336 |
|
Mesalazine 1.5g gast res MR gran sachets sugar free
0105010B0AAAUAU
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 1,319 |
|
Mesalazine 500mg gast res MR gran sachets sugar free
0105010B0AAAPAP
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 817 |
|
Mesalazine 500mg gastro-resistant tablets
0105010B0AAAWAW
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 729 |
|
Mesalazine 1.6g gastro-resistant tablets
0105010B0AABDBD
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 499 |
|
Mesalazine 4g modified-release granules sachets sugar free
0105010B0AABABA
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 481 |
|
Mesalazine 1g gastro-resistant tablets
0105010B0AABCBC
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 352 |
|
Mesalazine 250mg gastro-resistant tablets
0105010B0AAAHAH
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 180 |
|
Mesalazine 500mg/5ml oral liquid
0105010B0AAAVAV
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 4 |
|
Mesalazine 250mg suppositories
0105010B0AAAGAG
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | 3 |
|
Mesalazine 300mg/5ml oral suspension
0105010B0AABBBB
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
|
Mesalazine 400mg/5ml oral liquid
0105010B0AAAMAM
|
Mesalazine | Mesalazine (Systemic) | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.